SCHEMBL17593241

SCHEMBL17593241

Cn1nc(I)cc1C(=O)O

nearest known ligand 0.56

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
GRN P28799 5/20 0.56
SORT1 Q99523 5/20 0.56
KDM4E B2RXH2 3/20 0.56
CA12 O43570 1/20 0.38
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
CA9 Q16790 1/20 0.38
PKM P14618 1/20 0.38
HCAR3 P49019 1/20 0.36
PTPN1 P18031 1/20 0.35
MCL1 Q07820 2/20 0.35
GPR35 Q9HC97 1/20 0.35
ALDH1A1 P00352 2/20 0.35
GAA P10253 1/20 0.35
PHGDH O43175 3/20 0.34
HSD17B10 Q99714 2/20 0.33
GFER P55789 1/20 0.33
HPGD P15428 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31419626 0.82 KDM4E (0.38) GRNSORT1KDM4EPHGDH
SCHEMBL2546897 0.79 CA12 (0.42) GRNSORT1KDM4ECA12CA1
SCHEMBL15059353 0.77 GRN (0.58) GRNSORT1KDM4ECA12CA1
SCHEMBL286931 0.77 KDM4E (0.58) GRNSORT1KDM4ECA12CA1
SCHEMBL70171 0.77 KDM4E (0.58) GRNSORT1KDM4ECA12CA1
SCHEMBL16949533 0.76 KDM4E (0.53) GRNSORT1KDM4ECA12CA1
SCHEMBL1197293 0.75 KDM4E (0.56) GRNSORT1KDM4ECA12CA1
SCHEMBL1663229 0.75 GRN (0.56) GRNSORT1KDM4ECA12CA1
SCHEMBL19253450 0.75 GRN (0.56) GRNSORT1KDM4ECA12CA1
Hydrochloric Acid SCHEMBL9680540 0.75 KDM4E (0.56) GRNSORT1KDM4ECA12CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023205465-A1 HETEROARYL COMPOUNDS FOR THE TREATMENT OF PAIN VERTEX PHARMACEUTICALS INCORPORATED (US) 2023-10-26 WO disclosed
WO-2016040449-A1 3-PHOSPHOGLYCERATE DEHYDROGENASE INHIBITORS AND USES THEREOF RAZE THERAPEUTICS, INC. (US) 2016-03-17 WO disclosed